Key facts
- HAI Solutions’s last known valuation is $12.0M (Nov 2023).
- It has raised $2.5M.
- Notable investors include CONNECT (San Diego), American Association of Nurse Anesthetists, Anvaya Ventures, NuFund Venture Group, TiE SoCal Angels.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for HAI Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for HAI Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HAI Solutions
Developer of a fluid therapy device designed to protect patients from accidental or negligent disconnection of intravenous (IV) medications. The company's device is a single-use disposable device that delivers an underlying level of protection during IV fluid management by removing fluid particulates and eliminating microbes, and facilitates a multi-port with dual check valves, enabling patients to stay protected from bloodstream infections and diseases.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2015
- Employees
- 7
- Website
- hai-solutions.com/
- Ownership
- Privately Held (backing)
HAI Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HAI Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HAI Solutions in its N-PORT filings yet. We sweep new filings monthly.